The management of severe acute neurological patients is a constant medical challenge due to its complexity and dynamic evolution. Multimodal brain monitoring is an important tool for clinical decision at bedside. The datasets collected by the several brain monitors help to understand the physiological events of acute lesion and to define patient-specific therapeutic targets. We changed from pure neurological clinical evaluation to an era of structure and image definition associated with instrumental monitoring of pressure, flow, oxygenation, and metabolism. At each time, we want to assure perfect coupling between energy deliver and consumption, in order to ensure adequate cerebral blood flow and metabolism, avoid secondary lesion, and preserve normal tissue.
Introduction
The main purpose of neurocritical care is to fight brain cell death, giving adequate flow, oxygen, and glucose in order to promote neuronal, endothelial, and glial cell recovery to ensure neuronal function. Although clinical evaluation of comatose patients is still one of the foundations of clinical neuroscience, the neurological findings of adverse events appear too late in time. Multimodal brain monitoring may give crucial, real-time information about the dynamic evolution of brain lesion, allowing to avoid secondary injury, recognize adverse events, and improve individualized management of severe acute neurological patients admitted to Neurocritical Care Units (NCCU) [1] .
Basic neuromonitoring

Intracranial pressure, cerebral perfusion pressure, and autoregulation
Intracranial pressure (ICP) is derived from cerebral blood flow (CBF) and cerebrospinal fluid (CSF) circulation within the stiff skull [2] . The most reliable methods of ICP monitoring are ventricular catheters and intraparenchymal probes. An intraventricular drain connected to an external pressure transducer is still considered to be a ''golden standard'' method of measure global ICP. Ventricular catheters allow recalibration and therapeutic drainage of CSF but have significant complications, including hemorrhage, occlusion and infection. Intraparenchymal fiberoptic or microtransducer probes have a minimal associated risk of complications, but can be calibrated only before insertion although the sensitivity drift over time is very small. Critical values of ICP may vary between individual patients but current consensus is to treat ICP exceeding the 20 mmHg threshold [3] .
International guidelines for traumatic brain injury (TBI) recommend that ICP should be monitored in patients with Glasgow Coma Scale (GCS) score <8, with an abnormal head CT scan; or patients with GCS score <8 with a normal head CT scan if two or more of the following characteristics are present: age over 40 years, systolic blood pressure <90 mmHg or motor posturing [4, 5] . Recently, Chesnut et al. [6] published the results of the first randomized trial of ICP monitoring in patients with severe TBI. Six months after injury, patient groups had similar scores on functional status and cumulative mortality. For intensivists the strongest clinical implication of this trial is that we need to understand that the true value of ICP is more than a number and should become part of a multimodality approach to targeted therapy [7, 8] .
ICP beat-to-beat waveform consists of three components named P1, P2, and P3 that are related to arterial pulse and brain compliance (Figure 1) . P2 over P1 is a sensitive (99%) but not specific (1-17%) predictor of ICP subsequent increase [9] . Continuous ICP and arterial blood pressure monitoring allow calculation of cerebral perfusion pressure (CPP=ABP-ICP). CPP is the driving force of CBF and the principal determinant of cerebrovascular reactivity to pressure, named cerebral autoregulation. The normal cerebral arterial bed actively reacts to small fluctuations in arterial blood pressure in order to maintain constant CBF over a wide range of CPPs (from approximately 50-150 mmHg). When reactivity is normal the changes in ABP produce an inverse change in cerebral blood volume and hence ICP, but when reactivity is disturbed, changes in ABP are passively transmitted to ICP. Computational methods for continuous assessment of cerebral autoregulation were introduced more than a decade ago and they evaluate dynamic relationships between slow waves of ABP or CPP and ICP or flow velocity [10] . Examples of these methods are moving correlation coefficient, phase shift, or transmission (either in time-or frequency-domain).
The pressure reactivity index (PRx) is calculated as the moving correlation coefficient between 30 consecutive, 10 seconds averaged data points of ICP and ABP [11, 12] . A positive PRx (>0.2) signifies passive reactive vascular bed, while a PRx <0.2 means normal autoregulation. PRx may be used to continuous monitoring of autoregulation and define individual lower limit of autoregulation (LLA) and upper limit of autoregulation (ULA), helping target optimal CPP [13, 14] (Figure 2) . Retrospective studies show that favorable outcome reaches its peak when CPP is maintained close to optimal CPP [15] .
Oxygenation and cerebral blood flow
Brain resuscitation based on basic control of ICP and CPP does not prevent cerebral hypoxia in some patients [16] . Cerebral oxygenation monitoring evaluates the balance between oxygen delivery and consumption [17] and oxygen guided management could lead to improved neurologic outcome [18] . There are several invasive and non-invasive continuous methods of monitoring regional or global brain oxygenation and avoid secondary lesion due to hypoxia (jugular venous bulb oximetry, brain tissue oxygenation, and transcutaneous cerebral oximetry with near infrared spectroscopy).
Brain tissue oxygen pressure
Brain tissue oxygenation pressure (PbtO2) represents the interaction between plasma oxygen tension and CBF [19] . Direct measurement of local PbtO2 with an intraparenchymal probe is becoming the gold standard for oxygen monitoring in NCCU. PbtO2 probes are placed in the white matter and post-insertion head CT confirmation is needed to interpret readings. The normal range is 25-50 mmHg and PbtO2 <15 mmHg is considered the critical threshold for hypoxia [20, 21] . Algorithms of PbtO2-directed therapy should incorporate the management of the several causes of tissue hypoxia (hypoxic, anemic, ischemic, cytopathic, and hypermetabolic) [22] (Table 1) . Similarly to PRx, the index of tissue oxygen reactivity (ORx), calculated as the correlation coefficient between PbtO2 and CPP, can be used as an indicator of CBF autoregulation [23] . The concepts of cerebrovascular pressure reactivity and oxygen reactivity are related as high CPP should be avoided if it does not yield improvement in brain tissue oxygenation [24] .
Transcranial Doppler and thermal diffusion flowmetry
Continuous direct monitoring of CBF would be helpful to manage acute neurologic patients. Transcranial Doppler ultrasonography (TCD) is a non-invasive method to assess flow velocity as a surrogate of cerebral blood flow. TCD is more frequently used in the diagnosis of vasospasm or hyperemia, but may also be used as a tool to monitor the regulatory reserve of cerebral vasculature to changes in ABP, CO 2 , and transient hyperemic response test [25] [26] [27] . Thermal diffusion flowmetry (TDF) is based on thermal conductivity and provides a quantitative measurement of regional CBF. Probes are inserted in the white matter, 25 mm below the dura and the normal range is 18-25 ml/100g/min [28] . Continuous monitoring of CBF with TDF and CPP allows calculation of flow-related autoregulation index [29] .
Cerebral metabolism and electrical function
Brain metabolism can be assessed by hourly microdyalisis measurement of cell substrates (glucose), metabolites (lactate, pyruvate, glycerol), and neurotransmitters (glutamate) in the extracellular fluid [30] . Normal ranges are described in Table 2 . Cerebral microdyalisis detects early hypoxia and ischemia and increases the therapeutic window to avoid secondary lesion. However, remains to be established if treatment-related improvement in biochemistry translates into better outcome after acute brain injury [31] .
Continuous electroencephalography (cEEG) with or without video surveillance is becoming more widespread in the NCCU [32] . Modern cEEG approaches include quantitative analysis of total power, relative alpha variability and asymmetry detection. The most common indications are: detection of nonconvulsive seizures or status epilepticus, assessment of depth of sedation, detection of ischemia and characterization of clinical signs such as rigidity, tremors, eye deviation, agitation and otherwise unexplained variations of ABP and heart rate [33] . 
